Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.575 USD | +0.77% | +0.11% | +11.04% |
Apr. 17 | JonesTrading Starts Achieve Life Sciences With Buy Rating, $20 Price Target | MT |
Mar. 28 | Transcript : Achieve Life Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 257K | Capitalization | 157M |
---|---|---|---|---|---|
Net income 2024 * | -33M | Net income 2025 * | -37M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 609 x |
P/E ratio 2024 * |
-4.31
x | P/E ratio 2025 * |
-4.68
x | Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.59% |
Latest transcript on Achieve Life Sciences, Inc.
1 day | +0.77% | ||
1 week | +0.11% | ||
Current month | +0.66% | ||
1 month | -2.03% | ||
3 months | -10.99% | ||
6 months | +13.24% | ||
Current year | +11.04% |
Managers | Title | Age | Since |
---|---|---|---|
John Bencich
CEO | Chief Executive Officer | 47 | 14-07-31 |
Richard Stewart
CHM | Chairman | 65 | 15-04-30 |
Cindy Jacobs
PSD | President | 66 | 08-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vaughn Himes
BRD | Director/Board Member | 63 | 22-03-13 |
Thomas King
BRD | Director/Board Member | 69 | 23-03-28 |
Cindy Jacobs
PSD | President | 66 | 08-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 4.575 | +0.77% | 56,633 |
24-04-24 | 4.54 | +0.89% | 31,736 |
24-04-23 | 4.5 | +2.04% | 51,613 |
24-04-22 | 4.41 | -2.22% | 82,081 |
24-04-19 | 4.51 | -1.31% | 35,387 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.04% | 156M | |
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- ACHV Stock